Tremelimumab 300 Mg Inj,Carboplatin 150 Mg Inj,Bortezumab 2 Mg Inj,Gemcitabine 1400 Mg Inj,Gemcitab
By: MINISTRY OF DEFENCE - DEPARTMENT OF MILITARY AFFAIRS📍 IndiaClosed
Key Information
| Reference | GB-GEM/2026/B/8159849 |
|---|
| Deadline | Nov 11, 2026 12:00 AM |
|---|
| Category | Administration & Marketing |
|---|
| Competition Type | NCB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | India |
|---|
| Address | Country: India |
|---|
| Published | Nov 10, 2026 |
|---|
Description
Tremelimumab 300 Mg Inj,Carboplatin 150 Mg Inj,Bortezumab 2 Mg Inj,Gemcitabine 1400 Mg Inj,Gemcitab Quantity: 214 Start Date: 10-11-2026 12:00 PM End Date: 11-11-2026 12:00 PM Ministry of Defence...
Full details are available after unlocking this tender.